ARTICLE | Company News
Alaven Pharmaceutical LLC, Meda deal
October 18, 2010 7:00 AM UTC
Meda completed its previously announced acquisition of Alaven for $350 million in cash and the assumption of Alaven's debt. In August, Meda proposed to acquire Alaven for $287 million in cash and assu...